Larvol Delta - 1922GCCC-Pembro-and-Bavituximab-for-Squamous-Cell-Carcinoma-of-Head-and-Neck

Keytruda (pembrolizumab) - Merck (MSD)

Tarvacin (bavituximab) - OncXerna Therap

http://clinicaltrials.gov/ct2/show/NCT04150900

Mar 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next